These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 13029453)

  • 41. [Methylandrostenediol and its application in the treatment of premenstrual mastodynia].
    COSTA JE; GUGLIELMONE P
    Sem Med; 1955 Oct; 107(16):872-3. PubMed ID: 13281582
    [No Abstract]   [Full Text] [Related]  

  • 42. Low-dosage estrogen-androgen in the management of the menopausal syndrome and other estrogen deficiency states.
    MORAVEC CL; MORAVEC ME
    N Y State J Med; 1955 Oct; 55(19):2775-80. PubMed ID: 13266062
    [No Abstract]   [Full Text] [Related]  

  • 43. Methylandrostenediol: a non-virilizing derivative of testosterone in metastatic cancer of the breast.
    HOMBURGER F; KASDON SC; FISHMAN WH
    Proc Soc Exp Biol Med; 1950 May; 74(1):162-4. PubMed ID: 15430420
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical studies on the effect of methylandrostenediol therapy in infancy and childhood.
    AWWAAD S
    Arch Pediatr (N Y); 1954 Sep; 71(9):285-90. PubMed ID: 13208370
    [No Abstract]   [Full Text] [Related]  

  • 45. Hormonal therapy in cancer of the breast. II. Effect of methylandrostenediol on clinical course and hormonal excretion.
    SEGALOFF A; GORDON D; HORWITT BN; SCHLOSSER JV; MURISON PJ
    Cancer; 1952 Mar; 5(2):271-4. PubMed ID: 14905410
    [No Abstract]   [Full Text] [Related]  

  • 46. Methylandrostenediol in palliative treatment of breast cancer.
    KASDON SC; FISHMAN WH; DART RM; BONNER CD; HOMBURGER F
    J Am Med Assoc; 1952 Apr; 148(14):1212-6. PubMed ID: 14907362
    [No Abstract]   [Full Text] [Related]  

  • 47. Effective treatment of dysmenorrhea and menstrual molimina by the preovulatory administration of methyltestosterone or methylandrostenediol.
    KUPPERMAN HS; GOODMAN SJ
    Am J Obstet Gynecol; 1953 Jan; 65(1):141-9. PubMed ID: 13016681
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparative study of local changes in connective tissue induced by testosterone propionate, dehydroepiandrosterone, methylandrostenediol and cholesterol].
    RUBENS-DUVAL A; VILLIAUMEY J
    Ann Endocrinol (Paris); 1956 Oct; 17(5):637-41. PubMed ID: 13411661
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hypertelorism and infantile cataract due to probable adrenocortical dysfunction; effect of methylandrostenediol].
    FERIN J; FRANCOIS J; DEVIS R
    Ann Endocrinol (Paris); 1952; 13(3):377-81. PubMed ID: 13017079
    [No Abstract]   [Full Text] [Related]  

  • 50. [Methylandrostenediol in old age; preliminary note].
    MONTEYS PORTA J
    Rev Iber Endocrinol; 1956; 3(13):81-4. PubMed ID: 13310960
    [No Abstract]   [Full Text] [Related]  

  • 51. Oligospermia; a clinical study of treatment with methylandrostenediol.
    SCHULTZ JM
    Fertil Steril; 1956; 7(6):523-39. PubMed ID: 13375713
    [No Abstract]   [Full Text] [Related]  

  • 52. [Changes in the vaginal smear in rats treated with testosterone propionate and methylandrostenediol].
    BERLINGIERI D
    Arch Ostet Ginecol; 1959; 64():938-55. PubMed ID: 13799559
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of myotrophic and androgenic activities of 19-nortestosterone cyclopentylpropionate, androstanolone, and methylandrostenediol.
    BARNES LE; STAFFORD RO; GUILD ME; OLSON KJ
    Proc Soc Exp Biol Med; 1954 Oct; 87(1):35-8. PubMed ID: 13224668
    [No Abstract]   [Full Text] [Related]  

  • 54. [Testosterone propionate therapy of preclimacteric and climacteric disorders in women].
    KULAGO OI
    Akush Ginekol (Mosk); 1958; 34(6):50-2. PubMed ID: 13617145
    [No Abstract]   [Full Text] [Related]  

  • 55. [THE EFFECT OF ANDROGENS ON THE UTERINE AND VAGINAL MUCOSA IN CLIMACTERIC METRORRHAGIAS].
    JANATA J; FILIP O; STARKA L
    Zentralbl Gynakol; 1965 Apr; 87():463-9. PubMed ID: 14305904
    [No Abstract]   [Full Text] [Related]  

  • 56. Methylandrostenediol; a protein-anabolic steroid with little androgenic activity.
    GORDAN GS; EISENBERG E; MOON HD; SAKAMOTO W
    J Clin Endocrinol Metab; 1951 Feb; 11(2):209-12. PubMed ID: 14814201
    [No Abstract]   [Full Text] [Related]  

  • 57. [Androgen hormone therapy of climacteric disorders].
    SCHLOSSER W
    Med Welt (Stuttg); 1951 Oct; 20(42):1316-8. PubMed ID: 14899350
    [No Abstract]   [Full Text] [Related]  

  • 58. [Intravenous testosterone in regional circulatory disturbances due to ovarian dysfunction in the climacteric].
    FAUDA C; GIACOMINI M
    Minerva Med; 1949 Oct; 40(52):575-80. PubMed ID: 15394757
    [No Abstract]   [Full Text] [Related]  

  • 59. [Contribution to the study of the preventive treatment of surgical menopause by combined testosterone-estradiol].
    ESCARRAS A; MARMOTTANS A
    Mars Chir; 1950; 2(4):625-8. PubMed ID: 14805409
    [No Abstract]   [Full Text] [Related]  

  • 60. [Combination of estrogen and androgen hormones in the treatment of climacteric disorders].
    BUCHHOLZ HU
    Med Klin; 1957 Apr; 52(17):740-3. PubMed ID: 13440483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.